Tema 7. Shock séptico.
Tema 7. Shock séptico.
Recursos del bloque
Bibliografía recomendada:
1 The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) Singer M, Deutschman CS, Seymour CW, et al.
2 Assessment of clinical criteria for sepsis. Seymour CW, Liu V, Iwashyna TJ, et al.
3 Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2012. Dellinger RP, Levy MM, Rhodes A, et al.
4 Sepsis: pathophysiology and clinical management. Gotts JE, Matthay MA.
5 Procedimientos en Microbiología Clínica. In: SEIMC, editor. Recomendaciones de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica 3a Hemocultivos. Loza E, Planes A, Rodríguez M (2003).
6 Infectious Diseases Society of America/American Thoracic Society. Consensus guidelines on the management of community-acquired pneumonia in adults. Mandell LA, Wunderink RG, Anzueto A, et al.
7 Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Rosón B, Fernández-Sabé N, Carratalà J, et al.
8 Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Sordé R, Falcó V, Lowak M, et al.
9 Microbiological diagnosis of sepsis: polymerase chain reaction system versus blood cultures. Suberviola B, Márquez-López A, Castellanos-Ortega A, et al.
10 Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Kumar A, Roberts D, Wood KE, et al.
11 The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents. Blot SI, Pea F, Lipman J.
12 Optimizing dosing of antibiotics in critically ill patients. Parker SL, Sime FB, Roberts JA.
Otra bibliografía de interés:
1 Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Shankar-Hari M, Phillips GS, Levy ML, et al.
2 Sepsis definitions: time for change. Vincent J-L, Opal SM, Marshall JC, Tracey KJ.
3 Sepsis: a roadmap for future research. Cohen J, Vincent J-L, Adhikari NK, et al.
4 A randomized trial of protocol-based care for early septic shock. Yealy DM, Kellum JA, Juang DT, et al.
5 Goal-directed resuscitation for patients with early septic shock. The ARISE Investigators and the ANZICS Clinical Trials Group.
6 Trial of early, goal-directed resuscitation for septic shock. Mouncey PR, Osborn TM, Power GS, et al for the ProMISe trial investigators.
7 Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5 –year study. Levy MM, Rhodes A, Phillips GS, et al.
8 Sepsis-induced immune dysfunction: can immune therapies reduce mortality? Delano MJ,Ward PA.
9 The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Sterling SA, Miller WR, Pryor J.
10 GTEI-SEMICYUC recommendations for antibiotic treatment of gram positive coccal infections in the critical patient. Olaechea Astigarraga PM, Garnacho Montero J, Grau Cerrato S, et al.